|
US20030191279A1
(en)
|
1999-08-27 |
2003-10-09 |
Goldstein Steven Wayne |
Urea derivatives useful as anticancer agents
|
|
US6576632B1
(en)
|
1999-08-27 |
2003-06-10 |
Pfizer Inc |
Biaryl compounds useful as anticancer agents
|
|
BR0014076A
(pt)
|
1999-09-17 |
2002-10-15 |
Millennium Pharm Inc |
Benzamidas e inibidores correlatos do fator xa
|
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
HUP0203954A2
(hu)
|
1999-09-17 |
2003-03-28 |
Millennium Pharmaceuticals, Inc. |
Xa faktor inhibitorok
|
|
CA2387892A1
(en)
|
1999-10-18 |
2001-04-26 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
|
DK1259485T3
(da)
|
2000-02-29 |
2006-04-10 |
Millennium Pharm Inc |
Benzamider og beslægtede inhibitorer for faktor Xa
|
|
AU2001256981A1
(en)
|
2000-04-06 |
2001-10-23 |
Axys Pharmaceuticals, Inc. |
Cathepsin cysteine protease inhibitors
|
|
AU2002233206B2
(en)
|
2000-12-06 |
2006-06-22 |
Sanofi-Aventis Deutschland Gmbh |
Guanidine and amidine derivatives as factor xa inhibitors
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
CA2457922A1
(en)
|
2001-08-31 |
2003-03-13 |
University Of Connecticut |
Novel pyrazole analogs acting on cannabinoid receptors
|
|
WO2004002481A1
(en)
|
2002-06-27 |
2004-01-08 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
EP1581525A2
(en)
|
2002-08-09 |
2005-10-05 |
AstraZeneca AB |
Compounds having an activity at metabotropic glutamate receptors
|
|
JP2006506340A
(ja)
|
2002-08-09 |
2006-02-23 |
アストラゼネカ アクチボラグ |
代謝調節型グルタミン酸受容体５のモジュレーターとしてのオキサジアゾール
|
|
TW201018661A
(en)
|
2003-03-14 |
2010-05-16 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
WO2005019200A2
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
TWI316955B
(en)
|
2003-11-19 |
2009-11-11 |
Chisso Corp |
Photo-polymerization liquid composition,polymer or polymer co mposition and optical compensation device thereof
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
BRPI0507501A
(pt)
|
2004-02-18 |
2007-06-26 |
Astrazeneca Ab |
composto, composição farmacêutica, uso do composto, método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5
|
|
EP1729774A4
(en)
|
2004-03-09 |
2009-05-06 |
Nat Health Research Institutes |
PYRROLIDINE CONNECTIONS
|
|
DE112005001070T5
(de)
|
2004-05-21 |
2007-04-12 |
Merck Patent Gmbh |
Flüssigkristallverbindungen, Flüssigkristallmedium und Flüssigkristallanzeige
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
JP2008500991A
(ja)
|
2004-05-29 |
2008-01-17 |
７ティーエム ファーマ エイ／エス |
医学的使用のためのｃｒｔｈ２レセプターリガンド
|
|
WO2006015279A1
(en)
|
2004-07-28 |
2006-02-09 |
Neurogen Corporation |
Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders
|
|
US7652051B2
(en)
|
2004-08-25 |
2010-01-26 |
Targegen, Inc. |
Heterocyclic compounds and methods of use
|
|
KR101176677B1
(ko)
|
2004-09-06 |
2012-08-23 |
메르크 파텐트 게엠베하 |
중합성 액정 물질
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2006063113A2
(en)
|
2004-12-07 |
2006-06-15 |
Portola Pharmaceuticals, Inc. |
Ureas as factor xa inhibitors
|
|
AU2006205220B2
(en)
|
2005-01-10 |
2012-09-13 |
Exelixis, Inc. |
Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
|
|
US8084451B2
(en)
|
2005-01-10 |
2011-12-27 |
University Of Connecticut |
Heteropyrrole analogs acting on cannabinoid receptors
|
|
GB2424881B
(en)
|
2005-04-07 |
2010-11-24 |
Merck Patent Gmbh |
Halophenyl derivatives of bisalkylfluorene
|
|
WO2006113261A2
(en)
|
2005-04-14 |
2006-10-26 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
|
WO2006124447A2
(en)
|
2005-05-13 |
2006-11-23 |
Eli Lilly And Company |
Substituted n-arylpyrrolidines as selective androgen receptor modulators
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
WO2007024744A2
(en)
|
2005-08-21 |
2007-03-01 |
Exelixis, Inc. |
Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
|
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
WO2008035209A2
(en)
|
2006-05-30 |
2008-03-27 |
Methylgene Inc. |
Inhibitors of protein tyrosine kinase activity
|
|
MX2008015638A
(es)
|
2006-06-09 |
2009-01-09 |
Icos Corp |
Acidos fenil aceticos sustituidos como antagonistas de dp-2.
|
|
TW200815438A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
|
TW200815437A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
|
JP5606736B2
(ja)
|
2006-09-02 |
2014-10-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
反応性メソゲンを配向するための粒子ビーム法
|
|
PT2101760E
(pt)
|
2006-12-08 |
2013-05-07 |
Millennium Pharm Inc |
Formulações de dose unitária e métodos de tratamento da trombose com um inibidor oral do fator xa
|
|
JP2010513232A
(ja)
|
2006-12-15 |
2010-04-30 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
３−ｈ−ピラゾロピリジン類及びそれらの塩類、それらを含んで成る医薬組成物類、それらの調製方法及びそれらの使用
|
|
EP2125781A2
(en)
|
2006-12-20 |
2009-12-02 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
|
AU2008253118B2
(en)
|
2007-05-22 |
2013-11-21 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
KR101077417B1
(ko)
|
2007-06-12 |
2011-10-26 |
주식회사 엘지화학 |
위상차 필름, 이를 포함하는 편광판 및 액정 표시 장치
|
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
JP5057056B2
(ja)
|
2007-08-03 |
2012-10-24 |
Ｊｓｒ株式会社 |
液晶配向剤、液晶配向膜の製造方法、ポリアミック酸およびポリイミドならびにジアミン化合物
|
|
WO2009047105A1
(en)
|
2007-10-10 |
2009-04-16 |
Basf Se |
Sulphonium salt initiators
|
|
JP2009108152A
(ja)
|
2007-10-29 |
2009-05-21 |
Sumitomo Chemical Co Ltd |
重合性化合物および光学フィルム
|
|
WO2009078992A1
(en)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Linear tricyclic compounds as p38 kinase inhibitors
|
|
JP2009149754A
(ja)
|
2007-12-20 |
2009-07-09 |
Sumitomo Chemical Co Ltd |
重合性化合物および該重合性化合物を重合してなる光学フィルム
|
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
|
AR071480A1
(es)
|
2008-04-18 |
2010-06-23 |
Glaxo Group Ltd |
Compuesto de 1- ciano -3- pirrolidinil -bencenosulfonamida composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar la enfermedad pulmonar obstructiva cronica (copd )
|
|
TWI458721B
(zh)
|
2008-06-27 |
2014-11-01 |
Celgene Avilomics Res Inc |
雜芳基化合物及其用途
|
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
|
JP2010066630A
(ja)
|
2008-09-12 |
2010-03-25 |
Sumitomo Chemical Co Ltd |
光学フィルムの製造方法及び光学フィルム
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
MX2011006332A
(es)
|
2008-12-23 |
2011-06-27 |
Abbott Lab |
Compuestos antivirales.
|
|
KR101641385B1
(ko)
|
2009-03-16 |
2016-07-20 |
스미또모 가가꾸 가부시끼가이샤 |
화합물, 광학 필름 및 광학 필름의 제조 방법
|
|
JP5899607B2
(ja)
|
2009-03-16 |
2016-04-06 |
住友化学株式会社 |
化合物、光学フィルム及び光学フィルムの製造方法
|
|
JP2011006360A
(ja)
|
2009-06-26 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルム及び光学フィルムの製造方法
|
|
JP2011042606A
(ja)
|
2009-08-20 |
2011-03-03 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルム及び光学フィルムの製造方法
|
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
|
WO2011025706A2
(en)
|
2009-08-26 |
2011-03-03 |
Schering Corporation |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
WO2011053825A2
(en)
|
2009-10-30 |
2011-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment or prevention of mitochondrial diseases
|
|
CA2788355C
(en)
|
2010-02-18 |
2018-03-06 |
Devi Reddy Gohimukkula |
Phenyl-heteroaryl derivatives and methods of use thereof
|
|
CN110269856A
(zh)
|
2010-03-30 |
2019-09-24 |
维颂公司 |
多取代芳族化合物作为凝血酶的抑制剂
|
|
US8497265B2
(en)
|
2010-05-13 |
2013-07-30 |
Amgen Inc. |
Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
|
|
GB201010359D0
(en)
|
2010-06-21 |
2010-08-04 |
Univ Nottingham |
Compounds for treating proliferative disorders
|
|
AU2011283684B2
(en)
|
2010-07-29 |
2015-08-27 |
Rigel Pharmaceuticals, Inc. |
AMPK-activating heterocyclic compounds and methods for using the same
|
|
RS63320B1
(sr)
|
2010-12-08 |
2022-07-29 |
The U S A As Represented By The Secretary Department Of Health And Human Services |
Supstituisani pirazolopirimidini kao aktivatori glukocerebrozidaze
|
|
JP5728921B2
(ja)
|
2010-12-10 |
2015-06-03 |
コニカミノルタ株式会社 |
光学フィルム、及びそれを用いた偏光板、液晶表示装置
|
|
WO2012083059A1
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2012083048A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
RU2013150349A
(ru)
|
2011-04-13 |
2015-05-20 |
Мерк Шарп И Доум Корп. |
5-замещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов васе, содержащие их композиции и их применение
|
|
CA2834920A1
(en)
|
2011-05-23 |
2012-11-29 |
Sanofi |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
|
EP2739144A4
(en)
|
2011-06-20 |
2015-04-01 |
Alzheimer S Inst Of America Inc |
COMPOUNDS AND ITS THERAPEUTIC USE
|
|
US9845327B2
(en)
|
2011-06-22 |
2017-12-19 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
MX342326B
(es)
|
2011-09-27 |
2016-09-26 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
|
|
EP2763532B1
(en)
|
2011-10-05 |
2018-09-19 |
The Board of Trustees of the Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
|
EP2788332A1
(en)
|
2011-12-07 |
2014-10-15 |
Amgen, Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
WO2013106678A1
(en)
|
2012-01-12 |
2013-07-18 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
|
TW201348231A
(zh)
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
|
EP2671885A1
(en)
|
2012-06-05 |
2013-12-11 |
Ares Trading S.A. |
Imidazo-oxadiazole and Imidazo-thiadiazole derivatives
|
|
FR2992317B1
(fr)
|
2012-06-22 |
2016-05-13 |
Diverchim |
Procede de preparation de peptides chiraux
|
|
US10100253B2
(en)
|
2012-06-26 |
2018-10-16 |
Merck Patent Gmbh |
Method of preparing a birefringent polymer film
|
|
CA2883480A1
(en)
|
2012-09-17 |
2014-03-20 |
F. Hoffmann-La Roche Ag |
Usp30 inhibitors and methods of use
|
|
HK1211293A1
(en)
|
2012-11-02 |
2016-05-20 |
辉瑞公司 |
Bruton's tyrosine kinase inhibitors
|
|
BR112015009649A2
(pt)
|
2012-11-07 |
2017-07-04 |
Hoffmann La Roche |
composto de triazolo
|
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
|
CN105142641A
(zh)
|
2013-03-12 |
2015-12-09 |
广州源生医药科技有限公司 |
用于治疗癌症的化合物
|
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
|
JP2016512547A
(ja)
|
2013-03-14 |
2016-04-28 |
キュアジェニックス インコーポレイテッド |
線維症疾患の治療のための化合物
|
|
US9393244B2
(en)
|
2013-03-15 |
2016-07-19 |
Georgetown University |
Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
|
|
MX2015011180A
(es)
|
2013-03-15 |
2015-11-11 |
Hoffmann La Roche |
Derivados de aril sulfamida y sulfamato como moduladores del receptor huerfano relacionado con el receptor del retinoide (porc).
|
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
|
EP3019615B1
(en)
|
2013-07-12 |
2021-04-07 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Cystobactamides
|
|
WO2015010297A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
CA2918534A1
(en)
|
2013-07-25 |
2015-01-29 |
Fondazione Telethon |
Inhibitors of fapp2 and uses thereof
|
|
KR101715090B1
(ko)
|
2013-08-28 |
2017-03-13 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
|
SG11201602070TA
(en)
|
2013-09-30 |
2016-04-28 |
Beijing Synercare Pharma Tech Co Ltd |
Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
|
|
KR102243116B1
(ko)
|
2013-10-21 |
2021-04-22 |
메르크 파텐트 게엠베하 |
복굴절성 중합체 필름의 제조 방법
|
|
HUE044683T2
(hu)
|
2013-10-21 |
2019-11-28 |
Merck Patent Gmbh |
Heteroaril vegyületek mint BTK inhibitorok és alkalmazásuk
|
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
|
US9745324B2
(en)
|
2013-12-18 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
|
|
WO2015106292A1
(en)
|
2014-01-13 |
2015-07-16 |
Coferon, Inc. |
Bcr-abl tyrosine-kinase ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
DK3110420T3
(da)
|
2014-02-25 |
2019-05-13 |
Board Of Regents Univ Of Texas System |
Salte af heterocykliske modulatorer af hif-aktivitet til behandling af sygdomme
|
|
CN106459059B
(zh)
|
2014-05-13 |
2019-09-24 |
豪夫迈·罗氏有限公司 |
氘化杂环化合物和其作为成像剂的用途
|
|
KR102412045B1
(ko)
|
2014-05-22 |
2022-06-22 |
놀스 차이나 파마수티칼 컴퍼니., 엘티디. |
혈액응고인자 Xa 억제제로서의 히드라지드 화합물
|
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
GB201410653D0
(en)
|
2014-06-14 |
2014-07-30 |
Mission Therapeutics Ltd |
Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner
|
|
WO2015197028A1
(en)
|
2014-06-28 |
2015-12-30 |
Sunshine Lake Pharma Co., Ltd. |
Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
|
|
WO2016007534A1
(en)
|
2014-07-07 |
2016-01-14 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
US20170152226A1
(en)
|
2014-07-16 |
2017-06-01 |
Novogen Ltd. |
Functionalised and substituted indoles as anti-cancer agents
|
|
WO2016019237A2
(en)
*
|
2014-07-31 |
2016-02-04 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
|
US9290457B2
(en)
|
2014-07-31 |
2016-03-22 |
Boehringer Ingelheim International Gmbh |
Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
|
|
US10615343B2
(en)
|
2014-09-05 |
2020-04-07 |
Merck Patent Gmbh |
Formulations and electronic devices
|
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
|
GB201416754D0
(en)
|
2014-09-23 |
2014-11-05 |
Mission Therapeutics Ltd |
Novel compounds
|
|
US9997717B2
(en)
|
2014-12-12 |
2018-06-12 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescence device and electronic device
|
|
CN104557862B
(zh)
|
2014-12-15 |
2017-05-17 |
苏州云轩医药科技有限公司 |
具有Wnt信号通路抑制活性的杂环化合物
|
|
US10351532B2
(en)
|
2014-12-29 |
2019-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
|
|
CN107484415B
(zh)
*
|
2015-03-30 |
2021-01-29 |
特殊治疗有限公司 |
作为usp30抑制剂的1-氰基吡咯烷化合物
|
|
US11040976B2
(en)
|
2015-04-24 |
2021-06-22 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof
|
|
WO2017002120A1
(en)
|
2015-07-02 |
2017-01-05 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of senescent cells and uses thereof
|
|
WO2017010399A1
(ja)
|
2015-07-10 |
2017-01-19 |
塩野義製薬株式会社 |
ＲＯＲγｔ阻害作用を有する化合物およびそれらを含有する医薬組成物
|
|
EP3322702B1
(en)
|
2015-07-14 |
2019-11-20 |
Mission Therapeutics Limited |
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
|
|
WO2017019822A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Pellet composition containing repair cells
|
|
WO2017019817A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
|
WO2017019830A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
|
US11124483B2
(en)
|
2015-09-02 |
2021-09-21 |
The Regents Of The University Of California |
HER3 ligands and uses thereof
|
|
BR112018003622B8
(pt)
|
2015-09-04 |
2022-08-23 |
Dow Agrosciences Llc |
Moléculas apresentando utilidade pesticida, e composição pesticida
|
|
CA3001857A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
GB201521109D0
(en)
|
2015-11-30 |
2016-01-13 |
Mission Therapeutics Ltd |
Novel compounds
|
|
EP3386976A1
(en)
|
2015-12-09 |
2018-10-17 |
Research Triangle Institute, International |
Improved apelin receptor (apj) agonists and uses thereof
|
|
GB201522267D0
(en)
|
2015-12-17 |
2016-02-03 |
Mission Therapeutics Ltd |
Novel compounds
|
|
GB201522768D0
(en)
|
2015-12-23 |
2016-02-03 |
Mission Therapeutics Ltd |
Novel compounds
|
|
CN106986859B
(zh)
|
2016-01-20 |
2020-02-11 |
广东东阳光药业有限公司 |
吲哚衍生物及其用途
|
|
GB201602854D0
(en)
|
2016-02-18 |
2016-04-06 |
Mission Therapeutics Ltd |
Novel compounds
|
|
GB201603779D0
(en)
|
2016-03-04 |
2016-04-20 |
Mission Therapeutics Ltd |
Novel compounds
|
|
BR112018068703B1
(pt)
|
2016-03-16 |
2024-02-06 |
Kura Oncology, Inc. |
Inibidores substituídos de menin-mll e métodos de uso
|
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
GB201604647D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
WO2017163078A1
(en)
|
2016-03-24 |
2017-09-28 |
Mission Therapeutics Limited |
1-cyano-pyrrolidine derivatives as dbu inhibitors
|
|
CN107226805A
(zh)
|
2016-03-24 |
2017-10-03 |
北京天诚医药科技有限公司 |
芳香族酰胺类衍生物、其制备方法及其在医药上的应用
|
|
TW201811759A
(zh)
|
2016-06-29 |
2018-04-01 |
加拿大蒙特利爾大學 |
二芳基甲基雜環
|
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
|
CN107619384B
(zh)
|
2016-07-13 |
2020-07-28 |
江苏恒瑞医药股份有限公司 |
苯并杂环衍生物、其制备方法及其在医药上的应用
|
|
CN107674013B
(zh)
|
2016-08-02 |
2022-05-24 |
上海迪诺医药科技有限公司 |
多环化合物、其制备方法、药物组合物及应用
|
|
CA3035105C
(en)
|
2016-08-30 |
2023-09-12 |
Dow Global Technologies Llc |
Method of attenuating concentration of acrolein
|
|
CN109790112B
(zh)
|
2016-09-27 |
2022-08-26 |
特殊治疗有限公司 |
具有作为usp30抑制剂活性的氰基吡咯烷衍生物
|
|
GB201616511D0
(en)
|
2016-09-29 |
2016-11-16 |
Mission Therapeutics Limited |
Novel compounds
|
|
GB201616627D0
(en)
|
2016-09-30 |
2016-11-16 |
Mission Therapeutics Limited |
Novel compounds
|
|
TWI771327B
(zh)
|
2016-10-05 |
2022-07-21 |
英商使命醫療公司 |
新穎化合物
|
|
WO2018106820A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
JP7101685B2
(ja)
|
2017-01-20 |
2022-07-15 |
レオ ファーマ アクティーゼルスカブ |
新規ｊａｋキナーゼ阻害剤としての二環式アミン
|
|
WO2018146116A1
(en)
|
2017-02-08 |
2018-08-16 |
Helmholtz-Zentrum Dresden - Rossendorf E.V. |
In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics)
|
|
US10744213B2
(en)
|
2017-02-14 |
2020-08-18 |
Colossus Biopharma Consultants Company, Limited |
Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents
|
|
WO2018160891A1
(en)
|
2017-03-01 |
2018-09-07 |
Achillion Pharmaceutical, Inc. |
Pharmaceutical compounds for treatment of medical disorders
|
|
WO2018157856A1
(zh)
|
2017-03-03 |
2018-09-07 |
江苏豪森药业集团有限公司 |
酰胺类衍生物抑制剂及其制备方法和应用
|
|
US10968172B2
(en)
|
2017-05-15 |
2021-04-06 |
Mitobridge, Inc. |
USP30 inhibitors
|
|
GB201708652D0
(en)
|
2017-05-31 |
2017-07-12 |
Mission Therapeutics Ltd |
Novel compounds and uses
|
|
JP7208931B2
(ja)
|
2017-06-20 |
2023-01-19 |
ミッション セラピューティクス リミティド |
Ｄｕｂ阻害剤としての活性をもつ置換シアノピロリジン類
|
|
US11247987B2
(en)
|
2017-10-06 |
2022-02-15 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin specific peptidase 30
|
|
GB2571731A
(en)
|
2018-03-06 |
2019-09-11 |
Mission Therapeutics Ltd |
Novel compounds and uses
|
|
ES2988920T3
(es)
|
2018-05-17 |
2024-11-22 |
Forma Therapeutics Inc |
Compuestos bicíclicos fusionados útiles como inhibidores de la peptidasa 30 específica de ubiquitina
|
|
MX2021002981A
(es)
|
2018-10-05 |
2021-05-14 |
Forma Therapeutics Inc |
Pirrolinas fusionadas que actuan como inhibidores de la proteasa 30 especifica de la ubiquitina (usp30).
|